Procter & Gamble Health Fact Sheet, Procter & Gamble Health Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Procter & Gamble Health Fact Sheet    (EMER)


Top Stock to Buy: One stock with crorepati potential


Here is the latest financial fact sheet of Procter & Gamble Health. For more details, see the Procter & Gamble Health quarterly results and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.

PROCTER & GAMBLE HEALTH Price History

Price Rs 4,059.5
Mkt Cap Rs m 67,387
Vol '000 0.8
P/E X 41.0
P/CF X 54.8
EPS (TTM) Rs 99.1
% ch % 0.0
No. of shares m 16.60
% ch week % -3.2
% ch 1-mth % 1.8
% ch 12-mth % -6.2
52 week H/L Rs 5,120.8/2,927.8
(As on Jul 15, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PROCTER & GAMBLE HEALTH Financials

No. of Mths
Year Ending
12
Dec-14
12
Dec-15
12
Dec-16
12
Dec-17
12
Dec-18
5-Yr Chart
Click to enlarge
PROCTER & GAMBLE HEALTH EQUITY SHARE DATA
High Rs9191,0041,0601,3583,549 
Low Rs5367166239331,301 
Sales per share (Unadj.) Rs522.6566.0597.9420.6511.4 
Earnings per share (Unadj.) Rs26.032.345.736.861.3 
Diluted earnings per shareRs26.032.345.736.861.3 
Cash flow per share (Unadj.) Rs33.746.460.748.374.0 
Dividends per share (Unadj.) Rs6.007.5011.0015.00440.00 
Adj. dividends per shareRs6.007.5011.0015.00440.00 
Dividend yield (eoy) %0.80.91.31.318.1 
Book value per share (Unadj.) Rs333.9356.4388.8441.7927.8 
Adj. book value per shareRs333.9356.4388.8441.7927.8 
Shares outstanding (eoy) m16.6016.6016.6016.6016.60 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.41.51.42.74.7 
Avg P/E ratio x27.926.718.431.139.6 
P/CF ratio (eoy) x21.618.513.923.732.8 
Price / Book Value ratio x2.22.42.22.62.6 
Dividend payout %23.023.224.140.8717.9 
Avg Mkt Cap Rs m12,07514,27613,96919,01140,257 
No. of employees `0001.51.61.61.51.1 
Total wages/salary Rs m1,1361,2341,5421,0991,313 
Avg. sales/employee Rs Th5,726.06,045.76,270.14,521.67,486.7 
Avg. wages/employee Rs Th749.6794.0974.3711.71,157.6 
Avg. net profit/employee Rs Th285.3344.7479.4395.3897.2 
PROCTER & GAMBLE HEALTH INCOME DATA
Net Sales Rs m8,6759,3959,9266,9818,490 
Other income Rs m203233244241244 
Total revenues Rs m8,8789,62810,1707,2228,734 
Gross profit Rs m5898341,1067701,482 
Depreciation Rs m127234248191211 
Interest Rs m00000 
Profit before tax Rs m6668331,1028191,514 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00017066 
Tax Rs m233298343379563 
Profit after tax Rs m4325367596101,017 
Gross profit margin %6.88.911.111.017.5 
Effective tax rate %35.135.731.146.237.1 
Net profit margin %5.05.77.68.712.0 
PROCTER & GAMBLE HEALTH BALANCE SHEET DATA
Current assets Rs m4,9865,6436,3617,52315,343 
Current liabilities Rs m1,3521,5031,8642,2531,960 
Net working cap to sales %41.944.145.375.5157.6 
Current ratio x3.73.83.43.37.8 
Inventory Days Days7564608249 
Debtors Days Days4447396428 
Net fixed assets Rs m1,3731,3871,4061,2401,209 
Share capital Rs m166166166166166 
"Free" reserves Rs m5,3745,8446,4727,16715,235 
Net worth Rs m5,5435,9166,4557,33315,401 
Long term debt Rs m00000 
Total assets Rs m7,0827,7848,7929,91217,595 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x1.21.21.10.70.5 
Return on assets %6.16.98.66.25.8 
Return on equity %7.89.111.88.36.6 
Return on capital %12.014.117.113.510.3 
Exports to sales %7.88.58.800 
Imports to sales %22.821.622.300 
Exports (fob) Rs m67780286900 
Imports (cif) Rs m1,9812,0262,20900 
Fx inflow Rs m8248749591,0151,636 
Fx outflow Rs m2,3112,3562,6123,0434,368 
Net fx Rs m-1,487-1,483-1,653-2,028-2,732 
PROCTER & GAMBLE HEALTH CASH FLOW
From Operations Rs m 50 835 1,070 537 -1,304 
From Investments Rs m 106 -678 -750 -476 12,697 
From Financial Activity Rs m -166 -119 -150 -220 -301 
Net Cashflow Rs m -11 37 171 -160 11,093 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 51.8%
Indian inst/Mut Fund 18.2%
FIIs 1.0%
ADR/GDR 0.0%
Free float 29.1%
Shareholders 28,591
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Shiv Sagar Estate 'A', Dr. Annie Besant Road, Worli, Mumbai - 400 018
E-MAIL vikas.r.gupta@merckgroup.com WEB www.merck.co.in
TELEPHONE (022) 6660 9111 FAX (022) 2495 0307
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR B. S. R & Co.
CHM: S. N. Talwar COMP SEC: Vikas R. Gupta YEAR OF INC: 1967 BSE CODE: 500126 FV (Rs): 10 DIV YIELD (%): 10.8

Read: PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   AMAR REMEDIES  ALEMBIC LTD  SUN PHARMA  CIPLA  AJANTA PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   AMAR REMEDIES  ALEMBIC LTD  SUN PHARMA  CIPLA  AJANTA PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 750 Points from Day's High; Telecom and Energy Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours today and ended flat.

Views on news

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

How We Made 10%+ Profits Overnight (Fast Profits Daily)

Jul 3, 2020

A simple trade in natural gas delivered more than 10% overnight. Here's how we did it...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - MYLAN COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS